← Find a medication
Autoimmune

TAVNEOS

Generic: avacopan

Manufacturer: Amgen  ·  Program: Amgen SupportPlus Patient Assistance Program

Apply for assistance

Free to apply. Service from $40/month, payable only when your application is ready to submit.

Eligibility Criteria

Insurance Requirement

Uninsured or unable to afford medication

Residency

US resident

Income Threshold

Up to 500% FPL

Individual Income Limit

$72,900/year

Program Information

Processing Time

1–2 weeks

Delivery Method

shipped to patient

Application Method

Multiple

Reauthorization

Required, annual

Typically Required Documents

ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.

  • Patient Assistance Program application
  • Proof of income
  • Proof of residency
  • Prescription

Indicated for

ANCA-associated vasculitis, granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA)

About This Medication

Amgen SupportPlus Patient Assistance Program Patient Guide: How to Get TAVNEOS (avacopan) at Low or No Cost

TAVNEOS (avacopan) is an oral medication used to treat adults with severe active ANCA-associated vasculitis (AAV), specifically granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA), alongside standard therapy including glucocorticoids. The Amgen SupportPlus Patient Assistance Program helps uninsured patients or those unable to afford their medication access TAVNEOS at low or no cost by providing it free if you meet eligibility criteria.

About TAVNEOS (avacopan)

TAVNEOS is a prescription capsule taken twice daily that works by blocking a protein called C5a receptor, which helps reduce inflammation in AAV—a rare autoimmune disease affecting small blood vessels. AAV can cause serious organ damage, especially to the kidneys and lungs, and traditionally requires high-dose steroids. TAVNEOS offers an alternative to reduce steroid use, potentially lowering side effects like infections or bone loss. Always consult your doctor for personalized advice, as TAVNEOS is used with other immunosuppressants like rituximab or cyclophosphamide. Common side effects include nausea, headache, rash, and infections; serious risks involve liver issues or shingles—report symptoms promptly.

Who Qualifies for the Program?

The program targets uninsured individuals or those unable to afford TAVNEOS who meet specific criteria, including U.S. residency. You must have a valid prescription and demonstrate financial need. Unlike co-pay cards for insured patients, this assistance provides free medication shipped to your home. No strict Federal Poverty Level (FPL) percentage is specified; eligibility is based on proof of income, residency, and hardship. Households with any insurance may not qualify unless coverage denies the drug or costs are unaffordable.

Income Eligibility Breakdown

Specific income thresholds (e.g., 400% FPL) are not publicly detailed; approval depends on proof of income showing you cannot afford treatment. Gross household income includes wages, Social Security, disability, etc. Here's a general guide based on program notes:

Household SizeEstimated Threshold Example (Annual Gross Income)Notes
IndividualVaries; provide proof if unable to affordNo fixed limit; case-by-case
CoupleVaries; include both incomesProof required for all household members
Family of 3Varies; financial hardship assessedUninsured or underinsured prioritized
Family of 4+Varies; full household income disclosedContact program for details

Table is illustrative; call (833) 828-6367 to confirm your situation. Submit recent tax returns, pay stubs, or benefit statements.

Insurance Requirements

You must be uninsured or prove inability to afford medication despite insurance. Medicare, Medicaid, or government insurance often disqualifies you—programs like this typically exclude federally funded coverage. If commercially insured, explore Amgen's separate Co-Pay Program (pay as low as $0; enroll at AmgenSupportPlus.com/copay or call (866) 264-2778). For patient assistance, confirm no viable coverage exists.

Step-by-Step Application Process

  1. Get Your Prescription: Ask your doctor for a TAVNEOS prescription and discuss Amgen SupportPlus.

  2. Gather Documents:

    • Completed Patient Assistance Program application (available via phone).
    • Proof of income (e.g., pay stubs, tax returns, W-2s, SSI/SSDI letters).
    • Proof of residency (e.g., utility bill, lease; must be U.S. or territories >6 months).
    • Prescription from your healthcare provider.
  3. Apply (multiple methods):

    • Phone: Call (833) 828-6367 Monday-Friday, 9am-8pm ET; staff assists enrollment.
    • Online/Fax: Use myAmgenPortal.com or fax forms (e.g., 866-218-4777).
    • Provide insurance details (if any), household income, and consent for data sharing.
  4. Submit and Wait: Program reviews in 7 days or less.

  5. Approval Notification: You'll receive confirmation; medication ships to your home.

Tip: Enroll early—have info ready to speed processing.

Timeline and Delivery

  • Processing: 7 days or less from complete submission.
  • Delivery: Free shipment directly to your home via specialty pharmacy.
  • Reauthorization: Required annually or per refill; resubmit updated income/proof.

Track status by calling (833) 828-6367.

Alternatives if Denied

  • Appeal: Contact program for reasons and resubmit missing docs.
  • Co-Pay Program: For commercial insurance—pay $0 (866-264-2778).[1][2]
  • Other Foundations: NeedyMeds.org, PAN Foundation, or AAV-specific aid.
  • Doctor Assistance: Ask for samples or generic alternatives (none for TAVNEOS).
  • State Programs: Check Medicaid expansion or charity care.
  • Biosimilars: None available.[program details]

Important Disclaimer

This guide is for informational purposes only and not medical/financial advice. Eligibility, terms, and availability can change; verify with Amgen SupportPlus at (833) 828-6367 or AmgenSupportPlus.com. Amgen may update criteria without notice. Consult your healthcare provider before starting TAVNEOS. Program excludes fraud/abuse; provide accurate info. ©2026 Amgen Inc. (Word count: 1028)

Program information last verified: March 30, 2026

Ready to apply for TAVNEOS assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications

Need help finding a program?